Drug Resistance Tuberculosis Epidemic in India: A Review
Background: The emergence of drug-resistant tuberculosis (DR-TB), a challenging health condition to treat, poses serious problems for public health in India. Unfavorable socioeconomic conditions, limited access to healthcare and insufficient diagnostic tools all increase vulnerability. Comorbidities...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Light House Polyclinic Mangalore
2023-07-01
|
Series: | Online Journal of Health & Allied Sciences |
Subjects: | |
Online Access: | https://www.ojhas.org/issue86/2023-2-8.html |
_version_ | 1797767079028326400 |
---|---|
author | Pranay Deotale Nitish Mondal |
author_facet | Pranay Deotale Nitish Mondal |
author_sort | Pranay Deotale |
collection | DOAJ |
description | Background: The emergence of drug-resistant tuberculosis (DR-TB), a challenging health condition to treat, poses serious problems for public health in India. Unfavorable socioeconomic conditions, limited access to healthcare and insufficient diagnostic tools all increase vulnerability. Comorbidities also make it more difficult to treat TB and promote the development of DR-TB. Objectives: The primary goal of this review study was to focus particularly on the DR-TB epidemic in India. Our understanding of DR-TB will be expanded as a result of this study, which will also make it easier to develop focused interventions and public health regulations to deal with this problem. Methods: A meticulous systematic literature review was carried out using a wide range of electronic databases from around the world, including reputable sources. Results: The prevalence of DR-TB is rising over time. The main factors contributing to the disease's rising prevalence are genetic changes in Mycobacterium tuberculosis, and the appearance of comorbidities in TB patients. In contrast, these elements impair immunity, increase the likelihood of side effects from treatment, and promote the spread of DR-TB. Conclusion: To address the problems brought on by DR-TB, the TB epidemic necessitates a thorough, multi-sectoral approach. Initiatives for targeted public health education and awareness are essential to lowering the prevalence of DR-TB and improving general health outcomes in India. |
first_indexed | 2024-03-12T20:34:23Z |
format | Article |
id | doaj.art-861697d2cfe743d3bf9aa50b82fd91ad |
institution | Directory Open Access Journal |
issn | 0972-5997 |
language | English |
last_indexed | 2024-03-12T20:34:23Z |
publishDate | 2023-07-01 |
publisher | Light House Polyclinic Mangalore |
record_format | Article |
series | Online Journal of Health & Allied Sciences |
spelling | doaj.art-861697d2cfe743d3bf9aa50b82fd91ad2023-08-01T14:46:15ZengLight House Polyclinic MangaloreOnline Journal of Health & Allied Sciences0972-59972023-07-01222Drug Resistance Tuberculosis Epidemic in India: A ReviewPranay Deotale0Nitish Mondal1Research Scholar, Department of Anthropology, School of Human Sciences, Sikkim University, Gangtok 737102, Sikkim.Associate Professor, Department of Anthropology, School of Human Sciences, Sikkim University, Gangtok 737102, Sikkim.Background: The emergence of drug-resistant tuberculosis (DR-TB), a challenging health condition to treat, poses serious problems for public health in India. Unfavorable socioeconomic conditions, limited access to healthcare and insufficient diagnostic tools all increase vulnerability. Comorbidities also make it more difficult to treat TB and promote the development of DR-TB. Objectives: The primary goal of this review study was to focus particularly on the DR-TB epidemic in India. Our understanding of DR-TB will be expanded as a result of this study, which will also make it easier to develop focused interventions and public health regulations to deal with this problem. Methods: A meticulous systematic literature review was carried out using a wide range of electronic databases from around the world, including reputable sources. Results: The prevalence of DR-TB is rising over time. The main factors contributing to the disease's rising prevalence are genetic changes in Mycobacterium tuberculosis, and the appearance of comorbidities in TB patients. In contrast, these elements impair immunity, increase the likelihood of side effects from treatment, and promote the spread of DR-TB. Conclusion: To address the problems brought on by DR-TB, the TB epidemic necessitates a thorough, multi-sectoral approach. Initiatives for targeted public health education and awareness are essential to lowering the prevalence of DR-TB and improving general health outcomes in India.https://www.ojhas.org/issue86/2023-2-8.htmldrug-resistant tuberculosisindiacomorbiditiestreatment challengesdiagnosis challenges |
spellingShingle | Pranay Deotale Nitish Mondal Drug Resistance Tuberculosis Epidemic in India: A Review Online Journal of Health & Allied Sciences drug-resistant tuberculosis india comorbidities treatment challenges diagnosis challenges |
title | Drug Resistance Tuberculosis Epidemic in India: A Review |
title_full | Drug Resistance Tuberculosis Epidemic in India: A Review |
title_fullStr | Drug Resistance Tuberculosis Epidemic in India: A Review |
title_full_unstemmed | Drug Resistance Tuberculosis Epidemic in India: A Review |
title_short | Drug Resistance Tuberculosis Epidemic in India: A Review |
title_sort | drug resistance tuberculosis epidemic in india a review |
topic | drug-resistant tuberculosis india comorbidities treatment challenges diagnosis challenges |
url | https://www.ojhas.org/issue86/2023-2-8.html |
work_keys_str_mv | AT pranaydeotale drugresistancetuberculosisepidemicinindiaareview AT nitishmondal drugresistancetuberculosisepidemicinindiaareview |